EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target

Alan S Cross iD

Microbiology and Molecular Biology Reviews · 26.09.2023 · 87 (3)

DOI: 10.1128/mmbr.00045-22 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, erschienen am 26.09.2023. Verfasst von Alan S Cross. Beteiligte Einrichtung: Center for Vaccine Development and Global Health, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Anti-Infective Agents, Vaccines, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 336 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Affinivax, Inc/GSK, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections with antimicrobial-resistant (AMR) bacteria pose an increasing threat to the ability to perform surgical procedures, organ transplantation, and treat cancer among many other medical conditions. There are few new antimicrobials in the development pipeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsVaccinesGram-Negative Bacterial InfectionsHumansLipopolysaccharidesGram-Negative BacteriaBacteriaAnti-Bacterial Agents

Stichwörter der Autor:innen

Gram-negative bacteriaO polysaccharideantimicrobial resistanceendotoxinlipopolysaccharidevaccine

Substanzen

LipopolysaccharidesAnti-Infective AgentsVaccinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Vaccine Development and Global Health, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Alan S Cross

Förderung

  • NIAID NIH HHS
  • Affinivax, Inc/GSK
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Cross, A. S. (2023). Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. Microbiology and Molecular Biology Reviews, 87(3). https://doi.org/10.1128/mmbr.00045-22

Vancouver

Cross AS. Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. Microbiology and Molecular Biology Reviews. 2023;87(3). doi:10.1128/mmbr.00045-22

BibTeX
@article{Cross2023,
  author = {Cross, Alan S},
  title = {Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target},
  journal = {Microbiology and Molecular Biology Reviews},
  year = {2023},
  volume = {87},
  number = {3},
  doi = {10.1128/mmbr.00045-22}
}
Kostenlos starten →